Daily as of 3 Nov 16:00 ET
- Price
- above both $25.82 vs 50 $24.95 / 200 $20.24
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 1 Dec 2025 · projected 26 bars out
NRIX | Nurix TherapeuticsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$25.82
+$0.12 (+0.47%)
Nurix Therapeutics (NRIX) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2021.
The 50 SMA has sat above the 200 on the daily since Dec 2025, with no cross projected inside the 30 bars Cruxta tracks. Price sits above the 50 and the 200 on the daily, the weekly and the 4-hour.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- above both $26.80 vs 50 $19.81 / 200 $14.89
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross week of 4 May 2026 · projected 26 bars out · tested 1 bar
4-hour as of 3 Nov 16:00 ET
- Price
- above both $25.82 vs 50 $24.55 / 200 $24.19
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 27 May 2026 bar 2 · projected 10 bars out · tested 1 bar
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 27 May 2026 | 🟨Golden | 4-hour | 10 bars out | 1 bar cross test |
| week of 4 May 2026 | 🟨Golden moderate | weekly | 26 bars out | 1 bar cross test |
| 10 Mar 2026 | 💀Death | 4-hour | 26 bars out | 6 bar cross test |
| 1 Dec 2025 | 🟨Golden steep | daily | 26 bars out | Not tested |
| 4 Nov 2025 | 🟨Golden | 4-hour | 25 bars out | Not tested |
About NRIX
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$36.3M
4-hour coverageYes, since Oct 2025
History on recordSince 2021
SectorHealthcare
Cap bandmid